BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 25450449)

  • 1. Constructing a synthetic metabolic pathway in Escherichia coli to produce the enantiomerically pure (R, R)-2,3-butanediol.
    Ji XJ; Liu LG; Shen MQ; Nie ZK; Tong YJ; Huang H
    Biotechnol Bioeng; 2015 May; 112(5):1056-9. PubMed ID: 25450449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constructing a synthetic constitutive metabolic pathway in Escherichia coli for (R, R)-2,3-butanediol production.
    Tong YJ; Ji XJ; Shen MQ; Liu LG; Nie ZK; Huang H
    Appl Microbiol Biotechnol; 2016 Jan; 100(2):637-47. PubMed ID: 26428232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic operon for (R,R)-2,3-butanediol production in Bacillus subtilis and Escherichia coli.
    de Oliveira RR; Nicholson WL
    Appl Microbiol Biotechnol; 2016 Jan; 100(2):719-28. PubMed ID: 26454865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of (R)-1,3-butanediol production by engineered Escherichia coli using a bioreactor system with strict regulation of overall oxygen transfer coefficient and pH.
    Kataoka N; Vangnai AS; Ueda H; Tajima T; Nakashimada Y; Kato J
    Biosci Biotechnol Biochem; 2014; 78(4):695-700. PubMed ID: 25036969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of (R)-1,3-butanediol production by engineered Escherichia coli.
    Kataoka N; Vangnai AS; Tajima T; Nakashimada Y; Kato J
    J Biosci Bioeng; 2013 May; 115(5):475-80. PubMed ID: 23290993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysate of engineered Escherichia coli supports high-level conversion of glucose to 2,3-butanediol.
    Kay JE; Jewett MC
    Metab Eng; 2015 Nov; 32():133-142. PubMed ID: 26428449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial production of 2,3 butanediol from seaweed hydrolysate using metabolically engineered Escherichia coli.
    Mazumdar S; Lee J; Oh MK
    Bioresour Technol; 2013 May; 136():329-36. PubMed ID: 23567699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantioselective synthesis of pure (R,R)-2,3-butanediol in Escherichia coli with stereospecific secondary alcohol dehydrogenases.
    Yan Y; Lee CC; Liao JC
    Org Biomol Chem; 2009 Oct; 7(19):3914-7. PubMed ID: 19763290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic engineering of thermophilic Bacillus licheniformis for chiral pure D-2,3-butanediol production.
    Wang Q; Chen T; Zhao X; Chamu J
    Biotechnol Bioeng; 2012 Jul; 109(7):1610-21. PubMed ID: 22231522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased 2,3-butanediol production by changing codon usages in Escherichia coli.
    Park SY; Kim B; Lee S; Oh M; Won JI; Lee J
    Biotechnol Appl Biochem; 2014; 61(5):535-40. PubMed ID: 24527755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineering for the industrial production of 2,3-butanediol by the yeast, Saccharomyces cerevisiae.
    Mitsui R; Yamada R; Matsumoto T; Ogino H
    World J Microbiol Biotechnol; 2022 Jan; 38(3):38. PubMed ID: 35018511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of pure meso-2,3-butanediol from crude glycerol using an engineered metabolic pathway in Escherichia coli.
    Lee S; Kim B; Park K; Um Y; Lee J
    Appl Biochem Biotechnol; 2012 Apr; 166(7):1801-13. PubMed ID: 22434350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic engineering of Corynebacterium glutamicum for efficient production of optically pure (2R,3R)-2,3-butanediol.
    Kou M; Cui Z; Fu J; Dai W; Wang Z; Chen T
    Microb Cell Fact; 2022 Jul; 21(1):150. PubMed ID: 35879766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a commercial scale process for production of 1,4-butanediol from sugar.
    Burgard A; Burk MJ; Osterhout R; Van Dien S; Yim H
    Curr Opin Biotechnol; 2016 Dec; 42():118-125. PubMed ID: 27132123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of acetate accumulation leads to enhanced production of (R,R)-2,3-butanediol from glycerol in Escherichia coli.
    Shen X; Lin Y; Jain R; Yuan Q; Yan Y
    J Ind Microbiol Biotechnol; 2012 Nov; 39(11):1725-9. PubMed ID: 22832943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.
    Ying H; Tao S; Wang J; Ma W; Chen K; Wang X; Ouyang P
    Microb Cell Fact; 2017 Mar; 16(1):52. PubMed ID: 28347340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered E. coli W enables efficient 2,3-butanediol production from glucose and sugar beet molasses using defined minimal medium as economic basis.
    Erian AM; Gibisch M; Pflügl S
    Microb Cell Fact; 2018 Nov; 17(1):190. PubMed ID: 30501633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biocatalytic production of (2S,3S)-2,3-butanediol from diacetyl using whole cells of engineered Escherichia coli.
    Li L; Wang Y; Zhang L; Ma C; Wang A; Tao F; Xu P
    Bioresour Technol; 2012 Jul; 115():111-6. PubMed ID: 21937220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering of a butyraldehyde dehydrogenase of Clostridium saccharoperbutylacetonicum to fit an engineered 1,4-butanediol pathway in Escherichia coli.
    Hwang HJ; Park JH; Kim JH; Kong MK; Kim JW; Park JW; Cho KM; Lee PC
    Biotechnol Bioeng; 2014 Jul; 111(7):1374-84. PubMed ID: 24449476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic engineering of Klebsiella pneumoniae and in silico investigation for enhanced 2,3-butanediol production.
    Rathnasingh C; Park JM; Kim DK; Song H; Chang YK
    Biotechnol Lett; 2016 Jun; 38(6):975-82. PubMed ID: 26886192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.